Glem Lin 25/5mg Tablet is a combination medication containing two active ingredients: Empagliflozin and linagliptin. It is used in the treatment of type 2 diabetes mellitus to help control blood sugar levels.
Active Ingredients:
- Empagliflozin: Belongs to the class of medications known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. It works by inhibiting glucose reabsorption in the kidneys, leading to increased urinary excretion of glucose and thus lowering blood sugar levels.
- Linagliptin: Belongs to the class of medications known as dipeptidyl peptidase-4 (DPP-4) inhibitors. It works by increasing the levels of incretin hormones, which stimulate the release of insulin and inhibit the release of glucagon, thereby reducing blood sugar levels.
Uses:
Glem Lin 25/5mg Tablet is indicated for the management of type 2 diabetes mellitus in adults. It helps control blood sugar levels by different mechanisms: empagliflozin promotes the excretion of glucose in the urine, while linagliptin enhances insulin secretion and suppresses glucagon release.
Mechanism of Action:
- Empagliflozin inhibits the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, reducing the reabsorption of glucose and promoting its excretion in the urine.
- Linagliptin increases the levels of incretin hormones by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4), which in turn enhances insulin secretion and suppresses glucagon release, leading to lower blood sugar levels.
Administration:
Glem Lin 25/5mg Tablet is usually taken orally, once daily, with or without food. The dosage may vary depending on individual response and other factors. Patients should follow the dosage instructions provided by their healthcare provider.
Side Effects:
Common side effects of Glem Lin 25/5mg Tablet may include:
- Genital yeast infections
- Urinary tract infections
- Increased urination
- Thirst
- Nausea
- Diarrhea
- Hypoglycemia (low blood sugar)
Precautions:
Before using Glem Lin 25/5mg Tablet, patients should consider the following precautions:
- Inform healthcare providers of any known allergies to empagliflozin, linagliptin, or other medications.
- Monitor blood sugar levels regularly, especially during initial treatment or dosage adjustments.
- Use caution in patients with kidney problems or dehydration.
- Avoid excessive alcohol consumption, as it may increase the risk of hypoglycemia.
- Inform healthcare providers of any other medications, supplements, or herbal products being taken, as they may interact with Glem Lin 25/5mg Tablet.
Sana –